Psoriasis
Studies from National Hospital Organization provide new data on psoriasis
Published in Clinical Trials Week, May 10th, 2010
"This 24-week, placebo-controlled study evaluated the efficacy and safety of three different dosing regimens of adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis (n = 169). were randomized to receive adalimumab 40 mg every other week (eow), adalimumab 80-mg loading dose at week 0 followed by adalimumab 40 mg eow starting...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2010-05-10)
More Articles from Clinical Trials Week
- Clinical Trial Research
Findings from Swinburne University of Technology in clinical trial research reported - Helicobacter pylori
Scientists at Dokkyo Medical University, Department of Gastroenterology publish research in helicobacter pylori - Clinical Trial Research
Study data from Humboldt State University provide new insights into clinical trial research - Clinical Trial Research
Study results from University of Pennsylvania in the area of clinical trial research published - Clinical Trial Research
New findings from H. Silva and co-researchers in the area of clinical trial research described - Vomiting
New vomiting research from Cleveland Clinic discussed - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
